White

White-Swell is a clinical-stage medical device company developing a minimally invasive catheter-based system designed to treat acute decompensated heart failure (ADHF). The company's technology focuses on enhancing the natural clearance of excess interstitial fluid by creating a low-pressure zone at the outflow of the thoracic duct, thereby facilitating lymphatic drainage. By addressing the underlying congestion that standard diuretic therapies often fail to resolve, White-Swell aims to improve clinical outcomes and reduce hospital readmissions for heart failure patients. The system is currently being evaluated in clinical trials to establish its safety and efficacy in restoring fluid balance.